000 | 00896 a2200265 4500 | ||
---|---|---|---|
005 | 20250513085615.0 | ||
264 | 0 | _c19960412 | |
008 | 199604s 0 0 eng d | ||
022 | _a0140-6736 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPastor, C M | |
245 | 0 | 0 |
_aTreatment of hypotension in septic shock. _h[electronic resource] |
260 |
_bLancet (London, England) _cMar 1996 |
||
300 |
_a622; author reply 622-3 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAngiotensin II _xtherapeutic use |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNorepinephrine _xtherapeutic use |
650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVasoconstrictor Agents _xtherapeutic use |
700 | 1 | _aMorel, D R | |
773 | 0 |
_tLancet (London, England) _gvol. 347 _gno. 9001 _gp. 622; author reply 622-3 |
|
999 |
_c8595404 _d8595404 |